Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
411 studies found for:    meningitis
Show Display Options
Download search resultsDownload the search results for:
meningitis (411 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Ciprofloxacin for the Prevention of Meningococcal Meningitis
Condition: Meningitis, Meningococcal
Intervention: Drug: Ciprofloxacin
2 Recruiting Daptomycin in Pediatric Patients With Bacterial Meningitis
Condition: Meningitis
Intervention: Drug: Daptomycin
3 Completed Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis
Condition: Meningitis
Intervention: Drug: Meropenem
4 Recruiting Improving the Diagnosis of Meningitis in Emergency Rooms
Condition: Meningitis
Intervention: Other: Nasopharyngeal swab
5 Unknown  Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis
Condition: Cryptococcal Meningitis
Interventions: Drug: Liposomal amphotericin B;   Drug: Amphotericin B-deoxycholate
6 Completed Infant Severe Sepsis and Bacterial Meningitis in Malawi
Condition: Infant Bacterial Meningitis
Intervention: Drug: Ceftriaxone v penicillin and gentamicin
7 Recruiting Diagnostic Performance of Clinical Signs Patients Suspected of Meningitis to Emergencies
Condition: Meningitis
Intervention: Other: Non interventional study
8 Active, not recruiting Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae
Condition: Meningitis, Bacterial
Intervention:
9 Completed WEUSKOP6166: Lamotrigine and Aseptic Meningitis
Condition: Epilepsy
Intervention: Drug: Lamotrigine
10 Completed
Has Results
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
Condition: Cryptococcal Meningitis
Interventions: Drug: Amphotericin B;   Drug: Fluconazole
11 Completed Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Fixed dose - Stavudine, lamivudine and Nevirapine;   Drug: Fixed dose - Stavudine, Lamivudine, Nevirapine
12 Terminated
Has Results
DepoCyt for Active Lymphomatous or Leukemic Meningitis
Conditions: Neoplastic Meningitis;   Lymphoma, B Cell
Intervention: Drug: cytarabine liposome injection
13 Terminated Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
Conditions: Meningitis;   Neoplasms
Intervention: Drug: Gemcitabine
14 Completed Phase 1 Intrathecal Topotecan for Neoplastic Meningitis
Condition: Neoplastic Meningitis
Intervention: Drug: Topotecan
15 Completed Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF
Condition: Tuberculous Meningitis
Intervention:
16 Terminated IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis
Condition: Bacterial Meningitis
Interventions: Procedure: Mild induced hypothermia (32-34°C);   Procedure: local recommendations and guidelines
17 Completed Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis
Condition: Pneumococcal Meningitis
Intervention:
18 Completed Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Glycerol and paracetamol;   Drug: Paracetamol;   Drug: Placebo;   Drug: Paracetamol and glycerol;   Drug: Glycerol
19 Recruiting Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Infusion with paracetamol;   Drug: Bolus without paracetamol
20 Terminated Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
Condition: Cryptococcal Meningitis
Interventions: Biological: Efungumab (Mycograb);   Biological: placebo;   Biological: Amphotericin B;   Biological: 5 flucytosine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.